𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Carcinoma of Unknown Primary Site: Outcomes in Patients with a Colorectal Molecular Profile Treated with Site Specific Chemotherapy

✍ Scribed by Greco, F. Anthony; Lennington, Wayne J.; Spigel, David R.; Varadhachary, Gauri R.; Hainsworth, John D.

Book ID
120051213
Publisher
Scientific Research Publishing
Year
2012
Tongue
English
Weight
362 KB
Volume
03
Category
Article
ISSN
2151-1934

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Gemcitabine and docetaxel as front-line
Gemcitabine and docetaxel as front-line chemotherapy in patients with carcinoma of an unknown primary site
✍ Damien Pouessel; StΓ©phane Culine; Catherine Becht; Marc Ychou; Gilles Romieu; Mi πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 70 KB πŸ‘ 1 views

## Abstract ## BACKGROUND The current study was performed to evaluate the efficacy and toxicity of a noncisplatin‐based chemotherapy regimen combining gemcitabine and docetaxel as front‐line chemotherapy for patients with carcinoma of an unknown primary site. ## METHODS Patients were to receive

Gemcitabine and docetaxel as front-line
Gemcitabine and docetaxel as front-line chemotherapy in patients with carcinoma of an unknown primary site
✍ Alberto MuΓ±oz; JosΓ© RamΓ³n BarcelΓ³; Guillermo LΓ³pez-Vivanco πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 67 KB πŸ‘ 1 views

tional RCC and extensively cystic Bosniak Grade 2 or 3 disease, which may be difficult to diagnose reliably using either fine-needle or core-needle biopsy. Correlation of the results presented by Volpe et al. with the additional findings discussed in the current correspondence may be useful.